{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T15:11:04Z","timestamp":1778512264699,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Alice and Y.-T. Chen Pediatric Genetics and Genomics Center"},{"name":"National Mucopolysaccharidoses (MPS) Society"},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR001117"],"award-info":[{"award-number":["UL1TR001117"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH","award":["R01 HL081122"],"award-info":[{"award-number":["R01 HL081122"]}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH","award":["R01AR065873"],"award-info":[{"award-number":["R01AR065873"]}]},{"name":"NIH","award":["R01 GM086524"],"award-info":[{"award-number":["R01 GM086524"]}]},{"name":"NIH","award":["HL125905-01"],"award-info":[{"award-number":["HL125905-01"]}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH"},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.ymgme.2019.10.005","type":"journal-article","created":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T11:44:22Z","timestamp":1571312662000},"page":"73-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of antihypertensive drugs in combination with enzyme replacement therapy in mice with Pompe disease"],"prefix":"10.1016","volume":"129","author":[{"given":"Sang-oh","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexina C.","family":"Haynes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songtao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis M.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priya S.","family":"Kishnani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Steet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dwight D.","family":"Koeberl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2019.10.005_bb0005","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","article-title":"Recombinant human acid {alpha}-glucosidase: major clinical benefits in infantile-onset Pompe disease","volume":"68","author":"Kishnani","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2019.10.005_bb0010","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1023\/B:BOLI.0000031101.12838.c6","article-title":"Enzyme replacement and enhancement therapies for lysosomal diseases","volume":"27","author":"Desnick","year":"2004","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2019.10.005_bb0015","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","article-title":"A randomized study of alglucosidase alfa in late-onset Pompe\u2019s disease","volume":"362","author":"van der Ploeg","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2019.10.005_bb0020","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00415-009-5275-3","article-title":"Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial","volume":"257","author":"Strothotte","year":"2010","journal-title":"J. Neurol."},{"key":"10.1016\/j.ymgme.2019.10.005_bb0025","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ymgme.2011.02.006","article-title":"Enhanced efficacy of enzyme replacement therapy in Pompe disease through mannose-6-phosphate receptor expression in skeletal muscle","volume":"103","author":"Koeberl","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2019.10.005_bb0030","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ymgme.2011.11.005","article-title":"beta2 Agonists enhance the efficacy of simultaneous enzyme replacement therapy in murine Pompe disease","volume":"105","author":"Koeberl","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2019.10.005_bb0035","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1096\/fj.13-241893","article-title":"Adjunctive albuterol enhances the response to enzyme replacement therapy in late-onset Pompe disease","volume":"28","author":"Koeberl","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.ymgme.2019.10.005_bb0040","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ymgme.2015.09.012","article-title":"A beta-blocker, propranolol, decreases the efficacy from enzyme replacement therapy in Pompe disease","volume":"117","author":"Han","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2019.10.005_bb0045","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1136\/bmj.282.6279.1824","article-title":"Labetalol-induced toxic myopathy","volume":"282","author":"Teicher","year":"1981","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"key":"10.1016\/j.ymgme.2019.10.005_bb0050","doi-asserted-by":"crossref","first-page":"96","DOI":"10.7326\/0003-4819-114-1-96_2","article-title":"Metoprolol-induced polymyalgia-like syndrome","volume":"114","author":"Snyder","year":"1991","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ymgme.2019.10.005_bb0055","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1136\/bmj.2.6201.1331","article-title":"Proximal myopathy during beta-blockade","volume":"2","author":"Forfar","year":"1979","journal-title":"Br. Med. J."},{"key":"10.1016\/j.ymgme.2019.10.005_bb0060","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1086\/522236","article-title":"Enhanced response to enzyme replacement therapy in Pompe disease after the induction of immune tolerance","volume":"81","author":"Sun","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2019.10.005_bb0065","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.yjmcc.2005.02.023","article-title":"Skeletal muscle myofibrillar protein oxidation in heart failure and the protective effect of Carvedilol","volume":"38","author":"Dalla","year":"2005","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ymgme.2019.10.005_bb0070","doi-asserted-by":"crossref","first-page":"82ra37","DOI":"10.1126\/scitranslmed.3002227","article-title":"Losartan restores skeletal muscle remodeling and protects against disuse atrophy in sarcopenia","volume":"3","author":"Burks","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymgme.2019.10.005_bb0075","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1677\/joe.0.1490081","article-title":"GH regulation of the type 2 IGF receptor in regenerating skeletal muscle of rats","volume":"149","author":"Kirk","year":"1996","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ymgme.2019.10.005_bb0080","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0305-4179(98)00159-4","article-title":"Comparison of the anabolic effects and complications of human growth hormone and the testosterone analog, oxandrolone, after severe burn injury","volume":"25","author":"Demling","year":"1999","journal-title":"Burns"},{"key":"10.1016\/j.ymgme.2019.10.005_bb0085","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1465-9921-7-144","article-title":"Hypoxia and dehydroepiandrosterone in old age: a mouse survival study","volume":"7","author":"Debonneuil","year":"2006","journal-title":"Respir. Res."},{"key":"10.1016\/j.ymgme.2019.10.005_bb0090","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1046\/j.1365-2265.1998.00507.x","article-title":"The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women","volume":"49","author":"Morales","year":"1998","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ymgme.2019.10.005_bb0095","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.archoralbio.2006.01.003","article-title":"The expressions of insulin-like growth factors, their receptors, and binding proteins are related to the mechanism regulating masseter muscle mass in the rat","volume":"51","author":"Matsumoto","year":"2006","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.ymgme.2019.10.005_bb0100","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ymgme.2003.08.022","article-title":"Enzyme replacement therapy in the mouse model of Pompe disease","volume":"80","author":"Raben","year":"2003","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2019.10.005_bb0105","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/mt.2009.195","article-title":"Immunomodulatory gene therapy prevents antibody formation and lethal hypersensitivity reactions in murine pompe disease","volume":"18","author":"Sun","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2019.10.005_bb0110","doi-asserted-by":"crossref","first-page":"14555","DOI":"10.1073\/pnas.0804745105","article-title":"Beta-blockers alprenolol and carvedilol stimulate beta-arrestin-mediated EGFR transactivation","volume":"105","author":"Kim","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2019.10.005_bb0115","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1042\/bj2640573","article-title":"Effects of clenbuterol and propranolol on muscle mass. Evidence that clenbuterol stimulates muscle beta-adrenoceptors to induce hypertrophy","volume":"264","author":"MacLennan","year":"1989","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2019.10.005_bb0120","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3390\/ijms17020227","article-title":"Therapeutic effect of losartan, an angiotensin II type 1 receptor antagonist, on CCl(4)-induced skeletal muscle injury","volume":"17","author":"Hwang","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2019.10.005_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055427","article-title":"Losartan prevents heart fibrosis induced by long-term intensive exercise in an animal model","volume":"8","author":"Gay-Jordi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2019.10.005_bb0130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.lfs.2015.10.023","article-title":"Chronic effects of losartan on the muscles and the serologic profiles of mdx mice","volume":"143","author":"Lee","year":"2015","journal-title":"Life Sci."},{"key":"10.1016\/j.ymgme.2019.10.005_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138254","article-title":"Magnetic resonance imaging is sensitive to pathological amelioration in a model for laminin-deficient congenital muscular dystrophy (MDC1A)","volume":"10","author":"Vohra","year":"2015","journal-title":"PLoS One"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719219306791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719219306791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:26:12Z","timestamp":1761089172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719219306791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1096719219306791"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2019.10.005","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of antihypertensive drugs in combination with enzyme replacement therapy in mice with Pompe disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2019.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}